CIK 0002143850 · Pharmaceutical Preparations (SIC 2834) · Nasdaq · incorporated in DE · fiscal year ends 12/31
| Filed | Form | Description | Period |
|---|---|---|---|
| 2026-10-22 | SCHEDULE 13G | SCHEDULE 13G | |
| 2026-10-19 | 4 | OWNERSHIP DOCUMENT | 2026-10-19 |
| 2026-10-19 | 4 | OWNERSHIP DOCUMENT | 2026-10-15 |
| 2026-10-19 | 4 | OWNERSHIP DOCUMENT | 2026-10-15 |
| 2026-10-19 | 4 | OWNERSHIP DOCUMENT | 2026-10-15 |
| 2026-10-19 | 4 | OWNERSHIP DOCUMENT | 2026-10-19 |
| 2026-10-19 | 4 | OWNERSHIP DOCUMENT | 2026-10-15 |
| 2026-10-19 | 4 | OWNERSHIP DOCUMENT | 2026-10-15 |
| 2026-10-19 | 8-K | FORM 8-K items 5.03,9.01 | 2026-10-15 |
| 2026-10-16 | S-8 | FORM S-8 | |
| 2026-10-16 | 424B4 | 424B4 | |
| 2026-10-15 | EFFECT | EFFECT items ,, | |
| 2026-10-15 | S-1MEF | S-1MEF | |
| 2026-10-15 | 3 | OWNERSHIP DOCUMENT | 2026-10-15 |
| 2026-10-15 | 3 | OWNERSHIP DOCUMENT | 2026-10-15 |
| 2026-10-15 | 3 | OWNERSHIP DOCUMENT | 2026-10-15 |
| 2026-10-15 | 3 | OWNERSHIP DOCUMENT | 2026-10-15 |
| 2026-10-15 | 3 | OWNERSHIP DOCUMENT | 2026-10-15 |
| 2026-10-15 | 3 | OWNERSHIP DOCUMENT | 2026-10-15 |
| 2026-10-15 | 3 | OWNERSHIP DOCUMENT | 2026-10-15 |
| 2026-10-15 | 3 | OWNERSHIP DOCUMENT | 2026-10-15 |
| 2026-10-15 | 3 | OWNERSHIP DOCUMENT | 2026-10-15 |
| 2026-10-15 | 3 | OWNERSHIP DOCUMENT | 2026-10-15 |
| 2026-10-15 | 3 | OWNERSHIP DOCUMENT | 2026-10-15 |
| 2026-10-15 | CERT | CERT |
Forms on file (last 1,000): 3 11, 4 7, SCHEDULE 13G 1, 8-K 1, S-8 1, 424B4 1, EFFECT 1, S-1MEF 1. Source: SEC EDGAR, as filed; this page is public data and not investment advice.
GET https://store.agentexchange.work/gw/filings/company?ticker=CTY (0.002 USD), /gw/filings/filings?ticker=CTY&form=8-K, /gw/filings/facts?ticker=CTY&concept=Revenues, full-text /gw/filings/search?q=.... Pay per call in USDC (x402) or with a 19 USD card key for 1,000 calls. Catalogue · llms.txtUpdated from EDGAR within 30 minutes of a filing. Agent Exchange